Platinum

"Platinum" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A heavy, soft, whitish metal, resembling tin, with atomic number 78, atomic weight 195.084, symbol Pt. It is used in manufacturing equipment for laboratory and industrial use. It occurs as a black powder (platinum black) and as a spongy substance (spongy platinum) and may have been known in Pliny's time as "alutiae".

Descriptor ID	D010984
MeSH Number(s)	D01.268.556.690 D01.268.956.734 D01.552.544.690
Concept/Terms	Platinum Platinum Platinum Black

Below are MeSH descriptors whose meaning is more general than "Platinum".

Chemicals and Drugs [D]
Inorganic Chemicals [D01]
Elements [D01.268]
Metals, Heavy [D01.268.556]
Platinum [D01.268.556.690]
Transition Elements [D01.268.956]
Platinum [D01.268.956.734]
Metals [D01.552]
Metals, Heavy [D01.552.544]
Platinum [D01.552.544.690]

Below are MeSH descriptors whose meaning is more specific than "Platinum".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Platinum" by people in this website by year, and whether "Platinum" was a major or minor topic of these publications.

Bar chart showing 8 publications over 8 distinct years, with a maximum of 1 publications in 2005 and 2006 and 2007 and 2008 and 2012 and 2015 and 2016 and 2022

To see the data from this visualization as text, click here.

Year	Minor Topic	Total
2005	1	1
2006	1	1
2007	1	1
2008	1	1
2012	1	1
2015	1	1
2016	1	1
2022	1	1

Below are the most recent publications written about "Platinum" by people in Profiles.

Miron B, Handorf E, Zarrabi K, Zibelman MR, Anari F, Ghatalia P, Plimack ER, Geynisman DM. Influence of first-line chemotherapy regimen on survival outcomes of patients with advanced urothelial carcinoma who received second-line immune checkpoint inhibitors. Urol Oncol. 2022 10; 40(10):454.e9-454.e16.

View in: PubMed
Telli ML, Timms KM, Reid J, Hennessy B, Mills GB, Jensen KC, Szallasi Z, Barry WT, Winer EP, Tung NM, Isakoff SJ, Ryan PD, Greene-Colozzi A, Gutin A, Sangale Z, Iliev D, Neff C, Abkevich V, Jones JT, Lanchbury JS, Hartman AR, Garber JE, Ford JM, Silver DP, Richardson AL. Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer. Clin Cancer Res. 2016 08 01; 22(15):3764-73.

View in: PubMed
Luc G, Gronnier C, Lebreton G, Brigand C, Mabrut JY, Bail JP, Meunier B, Collet D, Mariette C. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S1357-64.

View in: PubMed
Gitlitz BJ, Tsao-Wei DD, Groshen S, Davies A, Koczywas M, Belani CP, Argiris A, Ramalingam S, Vokes EE, Edelman M, Hoffman P, Ballas MS, Liu SV, Gandara DR. A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: a California cancer consortium trial. J Thorac Oncol. 2012 Mar; 7(3):574-8.

View in: PubMed
Ramritu P, Halton K, Collignon P, Cook D, Fraenkel D, Battistutta D, Whitby M, Graves N. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units. Am J Infect Control. 2008 Mar; 36(2):104-17.

View in: PubMed
Takimoto CH, Graham MA, Lockwood G, Ng CM, Goetz A, Greenslade D, Remick SC, Sharma S, Mani S, Ramanathan RK, Synold TW, Doroshow JH, Hamilton A, Mulkerin DL, Ivy P, Egorin MJ, Grem JL. Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function. Clin Cancer Res. 2007 Aug 15; 13(16):4832-9.

View in: PubMed
Brown DB, Cai SR, Fundakowski CE, Zamboni WC, Strychor S, McLeod HL. Pharmacokinetics after endovascular lung perfusion with Cisplatin. J Vasc Interv Radiol. 2006 May; 17(5):883-8.

View in: PubMed
Eitan R, Levine DA, Abu-Rustum N, Sonoda Y, Huh JN, Franklin CC, Stevens TA, Barakat RR, Chi DS. The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma. Cancer. 2005 Apr 01; 103(7):1397-401.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement